Evaluation of the effect of duloxetine on the pharmacodynamics of warfarin at steady-state in healthy subjects
Phase of Trial: Phase I
Latest Information Update: 01 Oct 2008
At a glance
- Drugs Duloxetine; Warfarin
- Indications Cardiovascular disorders; Depressive disorders
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Eli Lilly
- 01 Oct 2008 Actual end date (Oct 2007) added as reported by ClinicalTrials.gov.
- 20 Dec 2007 Status changed from recruiting to completed.
- 06 Oct 2007 New trial record.